NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 149 filers reported holding NEWLINK GENETICS CORP in Q2 2015. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $237,000 | -9.2% | 32,691 | +1.6% | 0.01% | -7.7% |
| Q4 2017 | $261,000 | -18.2% | 32,166 | +2.7% | 0.01% | -27.8% |
| Q3 2017 | $319,000 | +31.3% | 31,327 | -5.1% | 0.02% | +28.6% |
| Q2 2017 | $243,000 | -69.3% | 32,999 | +0.6% | 0.01% | -69.6% |
| Q1 2017 | $791,000 | +109.8% | 32,816 | -10.6% | 0.05% | +91.7% |
| Q4 2016 | $377,000 | -46.2% | 36,704 | -21.3% | 0.02% | -46.7% |
| Q3 2016 | $701,000 | +29.3% | 46,645 | -3.0% | 0.04% | +21.6% |
| Q2 2016 | $542,000 | -35.2% | 48,109 | +4.6% | 0.04% | -39.3% |
| Q1 2016 | $837,000 | -44.8% | 46,007 | +10.5% | 0.06% | -47.0% |
| Q4 2015 | $1,515,000 | +564.5% | 41,644 | +587.5% | 0.12% | +400.0% |
| Q3 2015 | $228,000 | -75.5% | 6,057 | -71.2% | 0.02% | -76.0% |
| Q2 2015 | $932,000 | – | 21,044 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 93,533 | $962,000 | 1.69% |
| WALL STREET ASSOCIATES | 108,900 | $1,119,000 | 0.74% |
| NORTHWEST WEALTH MANAGEMENT, LLC | 57,482 | $591,000 | 0.60% |
| Orbimed Advisors | 1,991,700 | $20,475,000 | 0.26% |
| TFS CAPITAL LLC | 92,041 | $946,000 | 0.25% |
| Intrinsic Edge Capital Management LLC | 40,000 | $411,000 | 0.18% |
| SECOR Capital Advisors, LP | 100,529 | $1,033,000 | 0.13% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 176,077 | $1,810,000 | 0.12% |
| Piermont Capital Management Inc. | 41,400 | $426,000 | 0.10% |
| Vident Investment Advisory, LLC | 67,209 | $691,000 | 0.08% |